Factors Influencing Flu Vaccination in Primary Health Care (FIVA)
Primary Purpose
Flu, Human
Status
Completed
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
Brief educational intervention
Sponsored by
About this trial
This is an interventional prevention trial for Flu, Human focused on measuring Influenza Vaccines, Influenza, Human, Primary Health Care
Eligibility Criteria
Inclusion Criteria:
- People 65+ otherwise healthy;
- Patients of any age diagnosed with at least one of the following conditions: Diabetes, Asthma, COPD, Coronary Disease or Hearth failure;
- No history of flu vaccination in the previous year.
Exclusion Criteria:
- Patients who have been vaccinated against the flu but who have no record of it in the clinical records;
- Patients with contraindications to flu vaccination;
- Patients that cannot be reached either by phone or letter.
Sites / Locations
- Dão Lafões Grouping of Primary Health Care Centres
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patients receiving information
Arm Description
Patients in the experimental arm will receive a brief educational intervention if they initially refuse flu vaccination. The intervention was designed towards the most common barriers to flu vaccination that were found after a brief review of the literature. After the intervention, patients will be asked again whether or not they wish to receive the flu vaccine.
Outcomes
Primary Outcome Measures
Flu vaccination refusal rate
Percentage of patients refusing flu vaccination prior to intervention
Secondary Outcome Measures
Prevalence of barriers to flu vaccination
Percentage of participants mentioning a determined barrier to flu vaccination
Flu vaccination acceptance rate post-intervention
Percentage of patients who accept receiving the flu vaccine after receiving the intervention
Flu vaccination rate
Percentage of patients who have been vaccinated after the intervention
Full Information
NCT ID
NCT04097197
First Posted
September 18, 2019
Last Updated
May 29, 2020
Sponsor
Agrupamento de Centros de Saúde de Dão Lafões
1. Study Identification
Unique Protocol Identification Number
NCT04097197
Brief Title
Factors Influencing Flu Vaccination in Primary Health Care
Acronym
FIVA
Official Title
Factors Influencing Flu Vaccination in Primary Health Care
Study Type
Interventional
2. Study Status
Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
October 14, 2019 (Actual)
Primary Completion Date
March 31, 2020 (Actual)
Study Completion Date
March 31, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Agrupamento de Centros de Saúde de Dão Lafões
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to study the barriers to flu vaccination among at-risk people at the Primary Health Care level in order to increase the vaccination rates as recommended by the World Health Organization.
Detailed Description
People from vulnerable groups (e.g., those diagnosed with Diabetes, Chronic Obstructive Pulmonary Disease, Asthma) are at increased risk of developing complications from infection with influenza virus, that could ultimately result in death.
Flu vaccination is recommended by many authorities, including the World Health Organization, as a means to decrease the risk of developing such life-threatening conditions. However, vaccination rates are well below the recommended threshold.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Flu, Human
Keywords
Influenza Vaccines, Influenza, Human, Primary Health Care
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Before-after study
Masking
None (Open Label)
Allocation
N/A
Enrollment
197 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients receiving information
Arm Type
Experimental
Arm Description
Patients in the experimental arm will receive a brief educational intervention if they initially refuse flu vaccination. The intervention was designed towards the most common barriers to flu vaccination that were found after a brief review of the literature. After the intervention, patients will be asked again whether or not they wish to receive the flu vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Brief educational intervention
Intervention Description
same as before
Primary Outcome Measure Information:
Title
Flu vaccination refusal rate
Description
Percentage of patients refusing flu vaccination prior to intervention
Time Frame
up to 6 months
Secondary Outcome Measure Information:
Title
Prevalence of barriers to flu vaccination
Description
Percentage of participants mentioning a determined barrier to flu vaccination
Time Frame
up to 6 months
Title
Flu vaccination acceptance rate post-intervention
Description
Percentage of patients who accept receiving the flu vaccine after receiving the intervention
Time Frame
up to 6 months
Title
Flu vaccination rate
Description
Percentage of patients who have been vaccinated after the intervention
Time Frame
up to 6 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
People 65+ otherwise healthy;
Patients of any age diagnosed with at least one of the following conditions: Diabetes, Asthma, COPD, Coronary Disease or Hearth failure;
No history of flu vaccination in the previous year.
Exclusion Criteria:
Patients who have been vaccinated against the flu but who have no record of it in the clinical records;
Patients with contraindications to flu vaccination;
Patients that cannot be reached either by phone or letter.
Facility Information:
Facility Name
Dão Lafões Grouping of Primary Health Care Centres
City
Viseu
State/Province
Dão Lafões
ZIP/Postal Code
3514-511
Country
Portugal
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Factors Influencing Flu Vaccination in Primary Health Care
We'll reach out to this number within 24 hrs